Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Stopping Cymbalta can trigger a range of withdrawal effects, from flu like symptoms, dizziness, and electric shock sensations to mood swings and sleep disturbances as your body readjusts to lower neurotransmitter levels.
For guidance on safe tapering under medical supervision, self care strategies, symptom monitoring, and when to seek medical attention, see the full details below.
Cymbalta (generic name duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) often prescribed for chronic nerve pain, such as diabetic neuropathy or fibromyalgia. While it can provide significant relief, stopping Cymbalta—especially abruptly—can lead to withdrawal symptoms. Understanding what to expect and how to manage these effects can help you transition off the medication safely.
Cymbalta works by increasing levels of serotonin and norepinephrine in the brain and spinal cord, which can dampen pain signals. In addition to nerve pain, it's also approved to treat depression, generalized anxiety disorder, and chronic musculoskeletal pain. Because it affects neurotransmitters, your body may need time to readjust when you reduce or stop the medication.
People may consider stopping Cymbalta for various reasons:
Regardless of the reason, a safe discontinuation plan is essential to minimize withdrawal risks.
When you stop taking duloxetine, your body can react as it readjusts to lower levels of serotonin and norepinephrine. Common withdrawal symptoms include:
Symptoms vary in intensity and duration. Not everyone experiences every symptom, and some may notice mild effects while others have more pronounced reactions.
While individual experiences differ, a rough withdrawal timeline for duloxetine looks like this:
Taper Slowly
• Decrease the dose by no more than 10–25% every 2–4 weeks.
• Work with your doctor to create a personalized taper plan.
Monitor Symptoms
• Keep a daily log of physical and emotional changes.
• Note severity and triggers to share with your healthcare provider.
Stay Hydrated and Nourished
• Aim for a balanced diet rich in lean protein, whole grains, fruits, and vegetables.
• Drink plenty of water to ease headaches and muscle aches.
Practice Good Sleep Hygiene
• Establish a regular bedtime routine.
• Limit screen time before bed and create a calming environment.
Manage Stress
• Incorporate relaxation techniques such as deep breathing, meditation, or gentle yoga.
• Consider short daily walks or light exercise to boost mood and circulation.
Support Network
• Share your tapering plan with family or friends who can offer encouragement.
• Join online or local support groups for people discontinuing antidepressants.
While most withdrawal symptoms are uncomfortable but not dangerous, certain signs require prompt medical attention:
If you experience any of these, speak to a doctor or go to the nearest emergency department immediately.
If you're unsure whether your symptoms warrant medical attention, you can use this Medically approved LLM Symptom Checker Chat Bot to get guidance on your next steps and better understand what you're experiencing.
Evaluate Pain Management Alternatives
Speak with your healthcare provider about other medications, physical therapy, acupuncture, or topical agents that may help manage nerve pain.
Lifestyle Modifications
Incorporate regular, low-impact exercise such as swimming or walking. Maintain a healthy weight and control blood sugar if you have diabetic neuropathy.
Mental Health Support
Cognitive behavioral therapy (CBT) or other counseling approaches can help you cope with both pain and mood changes during and after tapering.
Regular Check-ins
Schedule follow-up appointments to assess pain levels, mood, and overall well-being.
By understanding what to expect and preparing ahead, you can navigate the discontinuation of Cymbalta more comfortably and safely.
(References)
* Cital S, Gupta C. Antidepressant discontinuation syndrome: a systematic review of the clinical picture, management and prevention. J Affect Disord. 2019 Mar 1;246:420-432. doi: 10.1016/j.jad.2018.12.067. Epub 2018 Dec 20. PMID: 30606771.
* Renjith V, Rajalekshmi S, Sanyal S. Antidepressant Discontinuation Syndrome. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: www.ncbi.nlm.nih.gov/books/NBK538421/
* Fava M, Ghaemi SN, Krystal JH, Trivedi MH. Managing pain after antidepressant withdrawal: a case series. Psychother Psychosom. 2017;86(6):380-381. doi: 10.1159/000481223. Epub 2017 Nov 24. PMID: 29279768.
* Zvolensky M, Mlynarik M, Tichá V, Tichý L, Zeleňáková J, Pindjakova J, Babickova P, Stofova Z. Neurobiological basis of antidepressant discontinuation syndrome: a systematic review. Braz J Psychiatry. 2023 Sep 25;45(5):418-425. doi: 10.47626/1516-4446-2023-3162. PMID: 37622616; PMCID: PMC10531515.
* Read J, Read J, Adebayo A, Dunsby J, Ladds J, Macleod J, Ross L, Steel B, Taylor L. Antidepressant tapering and discontinuation strategies: a narrative review of the evidence. Ther Adv Psychopharmacol. 2020 Oct 14;10:2045125320963321. doi: 10.1177/2045125320963321. PMID: 33139366; PMCID: PMC7565349.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.